DK0755382T3 - Quinolonderivat til behandling af urininkontinens - Google Patents

Quinolonderivat til behandling af urininkontinens

Info

Publication number
DK0755382T3
DK0755382T3 DK95915256T DK95915256T DK0755382T3 DK 0755382 T3 DK0755382 T3 DK 0755382T3 DK 95915256 T DK95915256 T DK 95915256T DK 95915256 T DK95915256 T DK 95915256T DK 0755382 T3 DK0755382 T3 DK 0755382T3
Authority
DK
Denmark
Prior art keywords
urinary incontinence
treatment
quinolone derivative
quinolone
derivative
Prior art date
Application number
DK95915256T
Other languages
English (en)
Inventor
John Edward Warawa
Cyrus John Ohnmacht Jr
Diane Amy Trainor
James Michael Hulsizer
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK0755382T3 publication Critical patent/DK0755382T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK95915256T 1994-04-14 1995-04-13 Quinolonderivat til behandling af urininkontinens DK0755382T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9407432A GB9407432D0 (en) 1994-04-14 1994-04-14 Heterocyclic derivative
PCT/GB1995/000845 WO1995028388A1 (en) 1994-04-14 1995-04-13 Quinolone derivative for treatment of urinary incontinence

Publications (1)

Publication Number Publication Date
DK0755382T3 true DK0755382T3 (da) 2001-09-10

Family

ID=10753541

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95915256T DK0755382T3 (da) 1994-04-14 1995-04-13 Quinolonderivat til behandling af urininkontinens

Country Status (25)

Country Link
EP (1) EP0755382B1 (da)
JP (1) JP3782445B2 (da)
KR (1) KR100344885B1 (da)
CN (1) CN1058708C (da)
AT (1) ATE202089T1 (da)
AU (1) AU700773B2 (da)
BR (1) BR9507366A (da)
CA (1) CA2187525C (da)
CZ (1) CZ284652B6 (da)
DE (1) DE69521310T2 (da)
DK (1) DK0755382T3 (da)
ES (1) ES2159633T3 (da)
FI (2) FI114705B (da)
GB (1) GB9407432D0 (da)
GR (1) GR3036482T3 (da)
HK (1) HK1013999A1 (da)
HU (1) HU215387B (da)
MX (1) MX9603920A (da)
NO (1) NO307177B1 (da)
NZ (1) NZ283779A (da)
PL (2) PL183095B1 (da)
PT (1) PT755382E (da)
RU (1) RU2149870C1 (da)
SK (1) SK281124B6 (da)
WO (1) WO1995028388A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60036476T2 (de) * 1999-08-03 2008-06-12 Abbott Laboratories, Abbott Park Kalium kanalaktivatoren
EP1307429B1 (en) * 2000-08-02 2007-11-28 AstraZeneca AB Process for asymmetric synthesis of substituted 1,4-dihydropyridines
SE0200205D0 (sv) * 2002-01-24 2002-01-24 Astrazeneca Ab Method
CN102532015B (zh) * 2012-01-18 2013-10-23 云南大学 香豆素及其类似物的固相合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2003148A1 (de) * 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate
GB9220570D0 (en) * 1991-10-21 1992-11-11 Ici Plc Therapeutic agent
GB9318935D0 (en) * 1992-10-20 1993-10-27 Zeneca Ltd Heterocyclic derivatives

Also Published As

Publication number Publication date
NO307177B1 (no) 2000-02-21
CA2187525C (en) 2006-01-24
DE69521310D1 (de) 2001-07-19
FI20040352A (fi) 2004-03-04
PL182031B1 (pl) 2001-10-31
KR100344885B1 (ko) 2002-11-30
GB9407432D0 (en) 1994-06-08
JPH09512254A (ja) 1997-12-09
EP0755382A1 (en) 1997-01-29
PL183095B1 (pl) 2002-05-31
PL316790A1 (en) 1997-02-17
GR3036482T3 (en) 2001-11-30
CN1146202A (zh) 1997-03-26
SK281124B6 (sk) 2000-12-11
HUT76132A (en) 1997-06-30
BR9507366A (pt) 1997-09-23
FI114705B (fi) 2004-12-15
AU2219995A (en) 1995-11-10
MX9603920A (es) 1997-04-30
CZ298196A3 (en) 1997-02-12
RU2149870C1 (ru) 2000-05-27
CN1058708C (zh) 2000-11-22
NO964345D0 (no) 1996-10-11
DE69521310T2 (de) 2002-04-18
CZ284652B6 (cs) 1999-01-13
PT755382E (pt) 2001-11-30
EP0755382B1 (en) 2001-06-13
FI964019A (fi) 1996-10-07
CA2187525A1 (en) 1995-10-26
HU9602747D0 (en) 1996-11-28
FI964019A0 (fi) 1996-10-07
ATE202089T1 (de) 2001-06-15
NO964345L (no) 1996-12-11
WO1995028388A1 (en) 1995-10-26
HU215387B (hu) 1998-12-28
ES2159633T3 (es) 2001-10-16
FI115630B (fi) 2005-06-15
AU700773B2 (en) 1999-01-14
SK131796A3 (en) 1997-05-07
HK1013999A1 (en) 1999-09-17
JP3782445B2 (ja) 2006-06-07
NZ283779A (en) 1998-02-26

Similar Documents

Publication Publication Date Title
FR12C0004I1 (da)
DE69725484D1 (de) Vorrichtung zur Behandlung von Harninkontinenz
DK0758904T3 (da) Fremgangsmåder og sammensætninger til behandling af glomerulonephritis
EP1407768A3 (en) The potassium channel opener retigabine for the treatment of diseases
WO2001010381A3 (en) Methods for treating or preventing pain and anxiety
DE69713347D1 (de) Flammbehandlungsverfahren
BR9703302A (pt) Aparelho e método para a geração e uso de ìons férricos
BR9713522A (pt) Método de uso de inibidores da cicloxigenase-2 como agentes antiangiogênicos.
DK0755382T3 (da) Quinolonderivat til behandling af urininkontinens
NZ509051A (en) Chemotaxis-inhibiting protein of staphylococcus (CHIPS) and its use
BR9813634A (pt) "abridores de canal de potássio"
DE69736180D1 (de) Behandlung von manischen erkrankungen
WO2002020031A3 (de) Verfahren von erythropoietin sowie dessen derivate zur behandlung von schizophrenie und verwandten psychosen
AU4882897A (en) Disinfectant composition, particularly for the prevention of dermatitis induced by diapers, and method for its use
DK1032580T3 (da) Fremgangsmåde til N-desmethylering af erythromyciner og derivater deraf
DK0673902T3 (da) Middel til behandling af bioaffald
EP0950411B8 (de) Verfahren zur Herstellung eines Extraktes aus Copalchirinde und Verwendung der Neoflavonoide zur Behandlung von Diabetes
BR0112460A (pt) Método para tratamento de sépsis
DK0737068T3 (da) 2,3-diaryl-1-benzopyraner til behandling af dermatitis
UA25164A (uk) Спосіб оперативhого лікуваhhя косоокості по в.і. ємчеhку
UA25165A (uk) Спосіб оперативhого лікуваhhя косоокості по в.і. ємчеhку
AU3974597A (en) Composition, process and method for treating grass by foliar application
BR7500223U (pt) Condensador para tratamento termovácuo de transformador
MX9709450A (es) Piridiniminil-1,2-benzoisoxazoles y -benzoisotiazoles como agentes antipsicoticos.
AU2196597A (en) Contact lens treating compositions, methods of treatment, and novel lenses